Search

everythinglearnresearchcommunity

for

Search:↓

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Low testosterone might be a common cause of hair loss in male dogs.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

A Shi Tzu dog with high cortisol levels improved after increasing the dose of trilostane.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

Finasteride improves hair growth in men with androgenetic alopecia.

Combining amino acid and stem cell therapy may help manage hepatocutaneous syndrome in dogs.

Treatment restored normal sexual characteristics and blood condition in a patient with testicular cancer.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Melatonin helps goat hair stem cells grow and maintain their ability to become different cell types.

Valproate can cause hair loss and changes in hair appearance, but may help regrow hair when applied topically.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Giving melatonin to sheep before the non-breeding season can improve their chances of reproducing in northwest Mexico.

Sodium valproate is not recommended as a first-line treatment for neuropathy but may be used in resistant cases.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.